LGC establishes its first laboratory facilities outside UK

LGC invests in German producer Mikromol

22-Jul-2003

LGC is pleased to announce the acquisition of Mikromol GmbH, world leader in the synthesis and sale of pharmaceutical impurities and metabolites as reference materials. This acquisition marks the first move by the Group to set up laboratory facilities outside the UK, with Mikromol becoming its location for pharmaceutical synthesis and a centre of excellence for all aspects of pharmaceutical impurities and metabolites.

The Board of LGC believes that the acquisition of Mikromol consolidates its position in reference standards and signals its commitment to the pharmaceutical and biotechnology industries. In particular, the Mikromol range of reference standards will strengthen the position of LGC Promochem as the specialist producer and distributor of reference standards to the pharmaceutical sector. LGC Promochem already enjoys a close relationship with US Pharmacopeia and is an established distributor of USP reference standards across Europe, India and elsewhere.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!

See the theme worlds for related content

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures
View topic world

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures